BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 11056092)

  • 1. Common cholesteryl ester transfer protein mutations, decreased HDL cholesterol, and possible decreased risk of ischemic heart disease: The Copenhagen City Heart Study.
    Agerholm-Larsen B; Tybjaerg-Hansen A; Schnohr P; Steffensen R; Nordestgaard BG
    Circulation; 2000 Oct; 102(18):2197-203. PubMed ID: 11056092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene.
    Agerholm-Larsen B; Nordestgaard BG; Steffensen R; Jensen G; Tybjaerg-Hansen A
    Circulation; 2000 Apr; 101(16):1907-12. PubMed ID: 10779455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesteryl ester transfer protein gene polymorphism is a determinant of HDL cholesterol and of the lipoprotein response to a lipid-lowering diet in type 1 diabetes.
    Dullaart RP; Hoogenberg K; Riemens SC; Groener JE; van Tol A; Sluiter WJ; Stulp BK
    Diabetes; 1997 Dec; 46(12):2082-7. PubMed ID: 9392500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. R451Q mutation in the cholesteryl ester transfer protein (CETP) gene is associated with high plasma CETP activity.
    Kakko S; Tamminen M; Kesäniemi YA; Savolainen MJ
    Atherosclerosis; 1998 Feb; 136(2):233-40. PubMed ID: 9543093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined analysis of six lipoprotein lipase genetic variants on triglycerides, high-density lipoprotein, and ischemic heart disease: cross-sectional, prospective, and case-control studies from the Copenhagen City Heart Study.
    Wittrup HH; Andersen RV; Tybjaerg-Hansen A; Jensen GB; Nordestgaard BG
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1438-45. PubMed ID: 16418216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study.
    Ordovas JM; Cupples LA; Corella D; Otvos JD; Osgood D; Martinez A; Lahoz C; Coltell O; Wilson PW; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1323-9. PubMed ID: 10807749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic variation of the cholesterol ester transfer protein gene and the prevalence of coronary artery disease. The AtheroGene case control study].
    Blankenberg S; Tiret L; Bickel C; Schlitt A; Jungmair W; Genth-Zotz S; Lubos E; Espinola-Klein C; Rupprecht HJ
    Z Kardiol; 2004; 93 Suppl 4():IV16-23. PubMed ID: 15085362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation.
    Inazu A; Brown ML; Hesler CB; Agellon LB; Koizumi J; Takata K; Maruhama Y; Mabuchi H; Tall AR
    N Engl J Med; 1990 Nov; 323(18):1234-8. PubMed ID: 2215607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial.
    Brousseau ME; O'Connor JJ; Ordovas JM; Collins D; Otvos JD; Massov T; McNamara JR; Rubins HB; Robins SJ; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1148-54. PubMed ID: 12117730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study.
    Borggreve SE; Hillege HL; Wolffenbuttel BH; de Jong PE; Zuurman MW; van der Steege G; van Tol A; Dullaart RP;
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3382-8. PubMed ID: 16684835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between a common variant of the cholesteryl ester transfer protein gene and the apolipoprotein E polymorphism: effects on plasma lipids and lipoproteins in a cohort of 7-year-old children.
    Rump P; Mensink RP; Hornstra G
    Nutr Metab Cardiovasc Dis; 2002 Dec; 12(6):317-24. PubMed ID: 12669678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesteryl ester transfer protein genetic polymorphisms, HDL cholesterol, and subclinical cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis.
    Tsai MY; Johnson C; Kao WH; Sharrett AR; Arends VL; Kronmal R; Jenny NS; Jacobs DR; Arnett D; O'Leary D; Post W
    Atherosclerosis; 2008 Oct; 200(2):359-67. PubMed ID: 18243217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four polymorphisms of cholesteryl ester transfer protein gene and coronary stenosis in a Tunisian population.
    Rejeb J; Omezzine A; Boumaiza I; Rebhi L; Rejeb NB; Nabli N; Abdelaziz AB; Boughzala E; Bouslama A
    J Cardiovasc Med (Hagerstown); 2012 Sep; 13(9):546-53. PubMed ID: 22854712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taq1B CETP polymorphism, plasma CETP, lipoproteins, apolipoproteins and sex differences in a Jewish population sample characterized by low HDL-cholesterol.
    Kark JD; Sinnreich R; Leitersdorf E; Friedlander Y; Shpitzen S; Luc G
    Atherosclerosis; 2000 Aug; 151(2):509-18. PubMed ID: 10924728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a common mutation (D442G) of the cholesteryl ester transfer protein gene on lipids and lipoproteins in children.
    Arashiro R; Katsuren K; Maung KK; Fukuyama S; Ohta T
    Pediatr Res; 2001 Oct; 50(4):455-9. PubMed ID: 11568287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of cholesteryl ester transfer protein -629C->A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides.
    Borggreve SE; Hillege HL; Wolffenbuttel BH; de Jong PE; Bakker SJ; van der Steege G; van Tol A; Dullaart RP;
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4198-204. PubMed ID: 15840744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol.
    Inazu A; Jiang XC; Haraki T; Yagi K; Kamon N; Koizumi J; Mabuchi H; Takeda R; Takata K; Moriyama Y
    J Clin Invest; 1994 Nov; 94(5):1872-82. PubMed ID: 7962532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers.
    Hannuksela ML; Liinamaa MJ; Kesäniemi YA; Savolainen MJ
    Atherosclerosis; 1994 Sep; 110(1):35-44. PubMed ID: 7857368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of the cholesteryl ester transfer protein I405V polymorphism with alcohol consumption in smoking and non-smoking healthy men, and the effect on plasma HDL cholesterol and apoAI concentration.
    Gudnason V; Thormar K; Humphries SE
    Clin Genet; 1997 Jan; 51(1):15-21. PubMed ID: 9084928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of plasma lipoproteins in patients heterozygous for human plasma cholesteryl ester transfer protein (CETP) deficiency: plasma CETP regulates high-density lipoprotein concentration and composition.
    Yamashita S; Hui DY; Wetterau JR; Sprecher DL; Harmony JA; Sakai N; Matsuzawa Y; Tarui S
    Metabolism; 1991 Jul; 40(7):756-63. PubMed ID: 1870431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.